These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17631234)

  • 21. Cutaneous drug reactions associated with newer antiretroviral agents.
    Martins CR
    J Drugs Dermatol; 2006; 5(10):976-82. PubMed ID: 17373147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model.
    Scott S; Mossong J; Moss WJ; Cutts FT; Cousens S
    Int J Epidemiol; 2008 Apr; 37(2):356-67. PubMed ID: 18234739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When to start antiretroviral therapy?
    Wilkin TJ; Gulick RM
    Clin Infect Dis; 2008 Dec; 47(12):1580-6. PubMed ID: 18990069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV-associated pulmonary hypertension ].
    Friese G; Lohmeyer J; Seeger W; Grimminger F; Ghofrani HA
    Herz; 2005 Sep; 30(6):481-5. PubMed ID: 16170678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The eldest of older adults living with HIV: response and adherence to highly active antiretroviral therapy.
    Brañas F; Berenguer J; Sánchez-Conde M; López-Bernaldo de Quirós JC; Miralles P; Cosín J; Serra JA
    Am J Med; 2008 Sep; 121(9):820-4. PubMed ID: 18724973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HIV infection in older patients: an emerging problem].
    Francisci D; Masini G; Belfiori B; Baldelli F
    Recenti Prog Med; 2008 Feb; 99(2):89-92. PubMed ID: 18459683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination antiretroviral therapy failure and HIV super-infection.
    Bezemer D; van Sighem A; de Wolf F; Cornelissen M; van der Kuyl AC; Jurriaans S; van der Hoek L; Prins M; Coutinho RA; Lukashov VV
    AIDS; 2008 Jan; 22(2):309-11. PubMed ID: 18097235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.
    Sungkanuparph S; Wongprasit P; Manosuthi W; Atamasirikul K
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):863-6. PubMed ID: 19058581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV prevalence in older adults.
    Eldred S; West L
    Can Nurse; 2005 Nov; 101(9):20-3. PubMed ID: 16350736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 and HIV-Associated Nephropathy 25 Years Later.
    Wyatt CM; Klotman PE
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S20-4. PubMed ID: 17699507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy.
    Franceschi S; Jaffe H
    Clin Infect Dis; 2007 Aug; 45(4):510-3. PubMed ID: 17638204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study.
    Poggensee G; Kücherer C; Werning J; Somogyi S; Bieniek B; Dupke S; Jessen H; Hamouda O;
    HIV Med; 2007 Nov; 8(8):511-9. PubMed ID: 17944684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV Infection in the elderly].
    Brañas F; Serra JA
    Rev Esp Geriatr Gerontol; 2009; 44(3):149-54. PubMed ID: 19443084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.